Background: Although a skin test is the primary option for detecting allergen-specific IgE in clinics, the serum IgE immunoassay is also important because it allows for the diagnosis of allergy without any accompanying adverse effect on the patient. However, the low detection limit of IgE levels by immunoassay may restrict the use of the method in some occasions, and improving its sensitivity would thus have a significant implication in allergy-immunology clinics. Methods: In this study, we attempted to detect specific serum IgE by using immuno-polymerase chain reaction (IPCR) which combines the antigen-antibody specificity of enzyme-linked immunosorbent assays (ELISAs) with the amplification power of PCR. Results: Our results demonstrated that Blo t5-specific serum IgE can be detected by IPCR with a 100-fold higher sensitivity than ELISA, and cross-reactivity of serum IgE to other mite allergens is able to be analyzed by using only 0.3 μl of serum sample. Use of real-time IPCR seemed to permit more convenient determination of specific serum IgE as well. Conclusion: We believe that IPCR can serve as a valuable tool in determining specific serum IgE, especially when the amount of serum sample is limited.
INTRODUCTION
Atopic allergic diseases affect 15% to 25% of the general population, and the prevalence of atopy and asthma are increasing in all developed countries for unknown reasons (1), implying that the importance of more accurate diagnosis is more demanding in allergy clinics. Skin testing is the primary and most sensitive method to detect allergen-specific IgE, and is considered as a clinical standard because of its routine usage in clinics for a long time. However, training and experience are required for both accuracy and consistency of the testing (2, 3) . In addition, skin testing cannot be performed in some occasions especially when a patient is taking a medication such as an anti-histamine or has extensive skin disease with a possible risk for systemic reaction such as anaphylaxis. Very young children, the elderly and women during pregnancy are not appropriate subjects for testing, either (4) .
Allergen-specific IgE also can be detected by immunoassays which permit the detection of specific serum IgE when the skin testing is impractical to perform. Immunoassays have been used for many diagnostic applications since the 1960s and a number of ways to detect a binding signal between analytes and antibodies have been developed. Especially, the use of labeled antibodies makes immunoassays more simple and convenient (5) . For instance, the radioallergosorbent test (RAST) is taking advantage of radioisotopic labels such as 125 I to measure specific serum IgE (6) . Recently, however, enzymes such as horseradish peroxidase and alkaline phosphatase have also been widely used as labels in the CAP system (7) because of easy handling as well as increased detection limits through the use of fluorogenic (8) or enzyme amplification methods (9, 10) . The CAP system is the most widely used currently (11) . However, they are generally less sensitive than the skin prick test, and it had been estimated through comparison studies that the sensitivity of immunoassays is about 70∼90% of epicutaneous skin testing (12) . Therefore, a discrepancy in diagnosis can occur in such a way that the skin test is positive, but the immunoassay is negative, mainly due to limitations of the immunoassay rather than problems with the skin test (13). Since the low detection limit of IgE by immunoassay appears to be problematic, improving the sensitivity of the immunoassay would have a significant implication in allergy-immunology clinics, particularly in the evaluation of asthma, rhinitis, atopic dermatitis or systemic anaphylaxis sensitized to drugs, latex or bee venom.
Previously, Sano et al. had developed the immuno-PCR (IPCR) method, extending the scope of PCR for the highly sensitive detection of proteins with as few as 10∼580 molecules of analyte (14) . Taking advantage of combining the molecular specificity of antibodies in enzyme-linked immunosorbent assays (ELISAs) with the amplification power of the PCR, the detection limit of a given ELISA can be enhanced 100∼10,000 fold by IPCR. The key feature of IPCR is the use of a specific antibody coupled to a reporter DNA molecule either by direct conjugation or via streptavidin-biotin interaction (15, 16) , which enables reflecting the amount of target protein bound by the antibodies to the amount of PCR product formed. The resulting PCR products are assessed either by gel electrophoresis (14, 17) , PCR-ELISA (18), or much more conveniently by using real-time PCR in which the amount of amplified DNA could be quantified sensitively and accurately over a wide concentration range (16, 19) . Currently, this method has become a well-established technique frequently applied in both fundamental and applied immunological research, and various target molecules including cytokines (20) (21) (22) , viral or bacterial proteins (23) (24) (25) (26) or specific serum IgG (27) , yet the detection of specific serum IgE antibodies to allergens has not been attempted so far. In this study, we describe the application of the IPCR assay in detecting specific-serum IgE and demonstrate that serum IgE specific for Blomia tropicalis group 5 allergen (Blo t 5), Dermatophagoides pteronyssinus group 1 (Der p 1) or 2 allergens (Der p 2) can be detected with high sensitivity.
MATERIALS AND METHODS
Preparation of sera and recombinant allergens Six sera from patients allergic to Blo t 5 and three cord blood sera, and recombinant mite allergens (Blo t 5, Der p 1 and Der p 2) (28) were kindly provided from Dr. Chua at National University of Singapore.
Enzyme-linked immunosobent assay (ELISA)
Maxisorp 96-well plates (Nunc, Denmark) coated with 50μl of 10μg/ml recombinant Blo t5 or glutathione S-transferase (GST). After coating at 4 o C overnight, each well was washed three times with phosphate-buffered saline (PBS) with 0.05% Tween 20 (PBST), and blocked with 200μl blocking buffer (PBS with 3% dry milk, pH 7.0) at room temperature for 1 h. After washing three times with PBST, 50μl of sera diluted appropriately with blocking buffer was added to each well, and incubated for 1 h at room temperature. After washing three times with PBST, 50μl of 40 ng/ml biotinylated goat anti-human IgE antibody (KPL, USA) in blocking buffer were added to each well and the plate was further incubated for 1 h at room temperature. Washing was performed three times with PBST again to remove unbound IgE, and streptavidin-horse radish peroxidase (HRPO) (Amersham Pharmacia, Sweden) conjugated antibody 1:2000 dilution in blocking buffer was added to each well and the plate was further incubated for 1 h at room temperature. The signal was visualized by adding 50 μl of the 3.3',5.5'-tetramethyl benzidine (TMB) substrate (Sigma Co.). The enzymatic reaction was terminated by adding an equal volume of 1 N HCl into each well. Absorbance at 450 nm was measured by using an ELISA reader (Biorad).
Preparation of reporter DNA Biotinylated double-stranded DNA (409 bp in size) was generated by PCR amplification of rice soluble starch synthease cDNA with a sense primer (5'-CTAGTGAGCAGGAGTCT-GAGATCATG-3', corresponding to nt 451∼476) and a biotinylated anti-sense primer (5'-GAGTGTGTATCTGAACTGA-TTATCGCC-3', corresponding to nt 836∼860). PCR was performed under the following condition: 10 mM Tris-HCl buffer (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM each deoxyribonucleotide, 0.1μM of each primer, 1.5 U of Ex-Taq polymerase (Takara) and 10 ng of pET22b containing full length After PCR amplification, the PCR product was purified using PCR cleanup kit (Promega, USA).
Immuno-PCR
The immuno-PCR (IPCR) was performed as described in the previous report with slight modifications (29) (Fig. 1) . Heat stable TopYield TM Strips (Nunc, Denmark) were coated with 30μl of 5μg/ml recombinant Blo t 5, Der p 1, Der p 2 or GST per well. After coating at 4 o C overnight, each well was washed three times with phosphate-buffered saline (PBS) with 0.05% Tween 20 (PBST), and blocked with 150μl blocking buffer (PBS with 3% dry milk, 5 mM EDTA and 1 μg/ml calf thymus DNA (Sigma Co., USA)) at room temperature for 1 h. After washing three times with PBST, 30μl of sera diluted appropriately with PBS containing 3% dry milk (PBSM) was added to each well, and incubated for 1 h at room temperature. Normal control serum was purchased from Sigma and included in the experiments. After washing three times with PBST, 30μl of 40 ng/ml biotinylated goat anti-human IgE antibody (KPL, USA) in PBS containing 0.5% bovine serum albumin (Sigma Co.) and 5 mM EDTA (PBSBE) were added to each well and the plate was further incubated for 1 h at room temperature. Washing was performed three times with PBST again to remove unbound IgE, and 100 ng/ml streptavidin (Sigma) (30μl/well) was added into each microwell. After incubation at room temperature for 30 min, the strips were washed three times with PBST, 6.5 ng/ml of the biotinylated DNA (30μl/well) was added, and the mixture was incubated at room temperature for 30 min. The stripes were washed six times with PBST and four times with sterile dH2O to remove unbound biotinylated DNA. The PCR was performed using a Perkin-Elmer Cetus 9600 instrument by adding 30μl of PCR mixture to each well. PCR reaction mixture contains 10 mM Tris-HCl (pH 8. Ten microliters of PCR product (371 bp) was analyzed using a 1.5% (w/v) agarose gel, followed by staining with ethidium bromide. DNA bands in the gel were visualized on a UV transilluminator and digitally photographed. Brightness/contrast of the resulting gel images was arbitrarily adjusted until background signal became invisible.
Real-time IPCR
Real-time IPCR was performed with ABI PRISM 7000 (Applied biosystems, USA) as above except that SYBR premix Ex-Taq (Takara, Japan), 0.1μM sense primer (5'-GCTCTTGCTCTT-CGTGGTCATC-3') and 0.1μM anti-sense primer (5'-GGAA-TCTTAATGTGCTTCTCAGTG-3') were used. The temperature profile was as follows: initial denaturation at 95 
RESULTS
Detection of serum IgE specific to Blo t 5 allergen by IPCR To measure serum titer of Blo t 5-specific IgE detected by Figure 2 . Comparison of the sensitivity of the Blo t 5-specific serum IgE detected by ELISA and the IPCR. Four-fold serial dilutions of the serum samples (patient #27 and #132, and cord blood CB2) were reacted with Blo t 5 mite allergen or GST (negative control antigen) that coated on the microtiter plate for standard ELISA or the heat stable TopYield TM Strips for the IPCR, respectively. In ELISA, streptavidin-conjugated with HRPO and TMB substrate were used to visualize binding signals, and analyzed at OD450nm. Data represent the average of three experiments±standard deviation. In the IPCR the PCR products were electrophoresed on a 1.5% agarose gel, and the DNA bands were visualized by EtBr staining. Brightness/contrast of the agarose gel picture was adjusted with Power Point software until the background PCR band of the 2° Ab only was just invisible. Details of the procedure are described in Materials and Methods. either conventional ELISA or our IPCR the sera from patients #27 and #132 were serially diluted with PBSM, and ELISA and IPCR were performed. Serum from cord blood #2 (CB2) was used as a negative serum control (Fig. 2) . ELISA data showed that Blo t 5-specific IgE was detected at a 1:640 dilution of the serum #27, whereas only at a 1:10 dilution of the serum #132 ( Fig. 2A) , implying that the serum #27 contains about 64-fold higher concentration of IgE for Blo t 5 allergen than the serum #132. GST was used as a negative antigen control, and no specific IgE binding was observed. When Blo t 5-specific IgE in the same serum samples was detected by IPCR, the reporter DNA band on the agarose gel was visible at the 1/10240 dilution of the serum #27, and at the 1/640 dilution of the serum #132 (Fig. 2B) . Thus, IPCR seemed about 64-fold more sensitive than ELISA in detecting specific serum IgE without considering the volume of serum samples applied in each assay (50 μl/well for ELISA and 30 μl/well for IPCR), and about 100-fold more sensitive than ELISA with considering the volume of serum samples applied in each assay.
We, then, performed IPCR with more number of serum samples to determine reliability of our approach to measure serum IgE specific to Blo t 5 allergen. Total six serum samples from the patients who are allergic to B. tropicalis and three cord blood samples (CB1, CB2 and CB3) were prepared, and IPCR was carried out using 1:100 dilution titer of the serum samples (Fig. 3) . The agarose gel analysis of the IPCR products revealed that all patients had serum IgE specific to Blo t 5 but at a different concentration, indicating that IPCR can be utilized successfully to detect Blo t 5-specific serum IgE by using only 300 nl of patient's serum. Expectedly, any significant PCR products were not observed either from the cord blood samples which were used as negative controls, or with GST, a negative antigen control. Among serum samples, the highest Blo t 5-specific serum IgE level was found in serum #27, and serum #132 had the lowest Blo t 5-specific serum IgE.
Real-time IPCR for detecting serum IgE specific for Blo t 5
Instead of analyzing PCR products by using agarose gel electrophoresis, we attempted Real-time IPCR since it enables us to quantify the amount of amplified DNA much more conveniently over a wide concentration range. To confirm the linearity of PCR amplification proportional to IgE concentration, the control experiments were performed using the TopYield TM Strips coated with anti-human IgE pAb and a pre-determined concentration of human IgE ranging from 12 ng/ml to 0. Linear PCR amplification curves were observed from 12 ng/ml to 187.5 pg/ml of IgE, and the detection limit of IgE was approximately 5.7 pg or 1.8×10 7 IgE molecules in our experimental setup (data not shown). As in Fig. 3 , nine different sera at 1:100 dilution were analyzed in the real-time IPCR to determine specific IgE for Blo t5 (Fig. 4A) and GST (Fig. 4B) . The amplification curves shown in Fig.  4 were exactly correlated with the amount of PCR products in Fig. 3 , yet real-time PCR was far more convenient in comparing the allergen-specific IgE levels between serum samples. Thereafter, the identical real-time IPCR was performed in triplicate to confirm the reproducibility of the experiments, and average and standard deviations were calculated with the threshold cycle (Ct) corresponding to a fluorescence threshold at the exponential phase of the amplification curves (Fig.  5A) . Well-to-well standard deviation was between 0.08 to 0.55 Ct, and all six Blo t 5-positive sera exhibited Cts below those of cord blood samples (CB), indicated by a dotted line, in a statistically significant manner, demonstrating the feasibility of the real-time IPCR in detecting specific serum IgE. As in the Fig. 4B no significant PCR products were obtained when GST was used to capture serum IgE, which are shown as no significant variation in Ct values among serum samples (Fig. 5B) .
Detection of serum IgE reactivity with other mite allergens by IPCR To determine the cross-reactivity of serum IgE to other mite allergens, IPCR was performed using a recombinant Der p 1 and Der p 2 allergen (Fig. 6) . Serum samples diluted at 1:100 were also utilized. The agarose gel analysis of the IPCR Figure 6 . Identification of the serum IgE reactivity to Der p 1 or Der p 2 mite allergens by the IPCR. The sera from nine different patients were diluted at 1:100, and mite allergen-specific IgE in the samples were determined by the IPCR using the TopYield TM Strips coated with Der p 1 or Der p 2. The resulting PCR products were electrophoresed on a 1.5% agarose gel, and the DNA bands were visualized by EtBr staining. Brightness/contrast of the agarose gel pictures was adjusted until the background PCR band of the 2° Ab only (Der p 1) or normal serum (Der p 2) disappeared using Power Point software.
products showed that five out of six samples (#30, #27, #24, #122 and #102) contain IgE that cross-reacts with Der p 1. Similarly, five out of six sera (#30, #24, #122, #132 and #102) also have Der p 2-specific serum IgE. It is interesting to note that the patient #27 seemed to have serum IgE specific for Blo t 5 and Der p 1, but not for Der p 2. To confirm the absence of Der p 2-specific IgE in the serum #27, the identical IPCR was carried out using 10-fold higher concentration of the serum, and no PCR product was obtained. In the case of the patient #132, serum IgE specific for Der p 1 was not detected.
DISCUSSION
One of disadvantages of the IgE immunoassays is a low detection limit that may produce discrepant results to the skin testing, and they usually require large quantities of serum samples to carry out. Since it is certain that improvement on the sensitivity of the immunoassay contributes to a more accurate diagnosis of allergic diseases, the ultra-sensitive IPCR method was applied to determine serum IgE against Blo t 5 allergen as a model.
As described by Sano et al. the IPCR allows the highly specific and sensitive detection of analyte by taking advantage of combining the antigen-antibody interaction with the amplification power of the PCR (14) . In a standard IPCR protocol, target-specific antibody is coupled to a reporter DNA either by direct conjugation or via streptavidin-biotin interaction (15, 16) , followed by PCR amplification of the reporter DNA of which copy number is directly proportional to specific antibody bound to a target molecule. Similarly, we utilized streptavidin to link biotinylated reporter DNA and biotinylated anti-human IgE antibody as in previous reports (17) . Various reporter DNA moieties originated from different sources including glyceraldehyde 3-phosphate dehydrogenase (G3PDH) (30) , pUC19 (31), pBluescript (22, 32) , λ phage DNA (33), α-hydroxynitrile lyase of the cassava plant (34), oligonucleotides (27) or the E. coli beta-glucuronidase (GUS) gene (35) had been successfully utilized without any functional differences. In this study, reporter DNA was designed from rice starch synthase cDNA, and milk solution was used as a blocking agent to improve signal-to-noise ratios (27) . Additionally, we had used a normal human serum which is commercially available to dilute patient's serum samples as previously reported by Lind and Kubista (16) , but found that the normal serum we used contains a low level of Der p 2-specific IgE, suggesting that careful attention must be paid in choosing a normal human serum for IPCR.
In the present report we demonstrate the feasibility of using IPCR for the sensitive detection of Blo t 5-specific IgE antibodies in human sera substantiated by perfect concordance between the IPCR and ELISA. It had been proposed that a 1000-to 10,000-fold increase in detection sensitivity can be obtained by IPCR compared to ELISA (14) , or even 100,000-to 1,000,000-fold lower concentrations of the target molecules can be detected by IPCR than those detected by western blot and ELISA (36) . In our experimental setup, however, we were able to achieve only 100-fold higher sensitivity than ELISA similar to the report by Lind and Kubista (16) . The exact cause of a lower sensitivity in our system is not known since PCR amplification in the IPCR can be affected by several factors including optimal concentration of reagents, presence of non-specific background noise and affinity of specific antibodies. From the experiment using human IgE standards, we were able to determine that our assay limit of IgE was about 187.5 pg/ml which is much higher than that of previous reports demonstrating successful detection of 100 ∼ 1 fg/ml of target molecules (22, 31, 36) . Most recently, however, the carefully scrutinized study by Niemeyer et al. (37) revealed that up to 10 pg/ml of IL-6 can be measured by the IPCR with antibody-streptavidin-reporter DNA conjugate, whereas 100 fg/ml of the molecule can be assayed by IPCR using a direct antibody-DNA conjugate. Indeed, we were also able to achieve the reproducible detection of up to 12 pg/ml IgE by using a 10-fold lower concentration of streptavidin (10 ng/ml) than that used in the present study (data now shown), and we assume that preparation of anti-human IgE secondary antibody directly conjugated with reporter DNA would be preferred for detection of lower IgE concentration in serum.
The significance of our study is that 0.3μl of serum is enough to detect allergen-specific serum IgE, whereas current serum IgE immunoassays such as ELISA, the RAST, and the CAP system require much larger quantities of serum samples. Allergy has become more prevalent recently and it has been estimated that the frequency of food allergies in infants is approximately 2∼5% (38) . Considering that only limited amounts of serum can be obtained from infants, application of IPCR in determining allergen-specific IgE can be a valuable tool since only 1 ml of serum is good enough to screen for over 300 of the most common allergens in a throughput manner. This is especially notable when taking advantage of real-time IPCR which has proved to be very useful in the assay by providing rapid and reproducible quantification of reporter DNA, and that analysis can be completed considerably faster than by conventional PCR. None of the assays currently used in the diagnosis of allergies has the high-throughput to screen for allergens, and the development of sophisticated technologies including microarrays are in progress to overcome present limitations (39) . Although we studied a small number of patient sera against a very limited number of mite allergens, our results clearly show that IPCR can be applied in diagnosing specific serum IgE in a dependable manner. Moreover, we believe that automation of the real-time IPCR assay format and calibration of the results in kIU/L would provide allergy clinicians with not only quantitative, but also multi-analytical measurements that will aid more accurate diagnosis of allergies.
